Tech Company Financing Transactions

Incline Therapeutics Funding Round

Incline Therapeutics closed a $43 million Series A funding round on 6/22/2010. Investors included Frazier Healthcare Partners, 5AM Ventures and Adams Harkness Ventures.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

900 Saginaw Dr. 200
Redwood City, CA 94063
USA

Phone

650-241-6800

Website

www.inclinethera.com

Email Address

[email protected]

Overview

Incline Therapeutics is a hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). Incline is financed by leading life science venture capital firms and led by a management team with significant pharmaceutical and medical device industry experience.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Alan Levy

        

Chief Operating Officer

David Socks

        

Chief Scientific Officer

Brad Phipps

        

President

David Socks

        

VP - Engineering

John Lemke

        

VP - Manufacturing

Mike Ramsay

        

VP - Product Management

Nitin Joshi

        

VP - Regulatory Affairs

Patti Oto

        

Browse more venture capital transactions:

Prev: 6/22/2010: Brand.net venture capital transaction
Next: 6/22/2010: Quantalife venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary